U.S. Supreme Court to review lawsuits over flaws in generic drugs
The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain.
LATEST NEW HAMPSHIRE ANGLE
Nashua high schools keep reduced SRO staffing; school board approves budget reduction list, principal contract
HarborCorp developers state their case
Joe McQuaid's Publisher's Notes: Cover your ears, little children, Uncle Stacey has a story that will shock the news media
Joe McQuaid's Publisher's Notes: The 'professionals' may say Trump is unpolished, but voters may find him more than an apprentice